Twist Bioscience (TWST) Other Operating Expenses (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Other Operating Expenses data on file, last reported at $53.6 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $53.6 million, up 14.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.3 million (up 11.53% YoY), and the FY2023 annual result was $5.9 million, down 58.49% from the prior year.
• Other Operating Expenses improved to $53.6 million in Q1 2026 per TWST's latest filing, from $49.7 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $53.6 million in Q1 2026 and troughed at -$48.8 million in Q3 2025.
• A 5-year average of $17.8 million and a median of $5.1 million in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 324.22% in 2022, then tumbled 86.27% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $4.1 million in 2022, then sank by 85.95% to $581000.0 in 2023, then jumped by 7795.52% to $45.9 million in 2024, then rose by 8.4% to $49.7 million in 2025, then increased by 7.78% to $53.6 million in 2026.
• Business Quant data shows TWST's Other Operating Expenses at $53.6 million in Q1 2026, $49.7 million in Q4 2025, and -$48.8 million in Q3 2025.